Cite
HARVARD Citation
Ylstra, B. et al. (n.d.). Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer. European journal of cancer. pp. S29-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ylstra, B. et al. (n.d.). Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer. European journal of cancer. pp. S29-. [Online].